Cargando…
Targeting NRF2 for the Treatment of Friedreich’s Ataxia: A Comparison among Drugs
NRF2 (Nuclear factor Erythroid 2-related Factor 2) signaling is impaired in Friedreich’s Ataxia (FRDA), an autosomal recessive disease characterized by progressive nervous system damage and degeneration of nerve fibers in the spinal cord and peripheral nerves. The loss of frataxin in patients result...
Autores principales: | Petrillo, Sara, D’Amico, Jessica, La Rosa, Piergiorgio, Bertini, Enrico Silvio, Piemonte, Fiorella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829337/ https://www.ncbi.nlm.nih.gov/pubmed/31640150 http://dx.doi.org/10.3390/ijms20205211 |
Ejemplares similares
-
The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich’s Ataxia
por: La Rosa, Piergiorgio, et al.
Publicado: (2020) -
Ferroptosis in Friedreich’s Ataxia: A Metal-Induced Neurodegenerative Disease
por: La Rosa, Piergiorgio, et al.
Publicado: (2020) -
Nrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich’s Ataxia Neural Stem Cells
por: La Rosa, Piergiorgio, et al.
Publicado: (2019) -
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia
por: La Rosa, Piergiorgio, et al.
Publicado: (2020) -
Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich’s Ataxia
por: Petrillo, Sara, et al.
Publicado: (2017)